Protocol 10608, "A phase II trial of durvalumab with gemcitabine and cisplatin as neoadjuvant therapy for high-risk resectable intrahepatic cholangiocarcinoma" (NCT TBD)

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

University of Colorado Hospital

Principal Investigator
Photograph of Sarah Davis

Sarah Davis

Study ID

Protocol Number: 24-0573

More information available at ClinicalTrials.gov: NCT06050252

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers